21 CFR 312.87 - Active monitoring of conduct and evaluation of clinical trials.

Regulations last checked for updates: May 01, 2025

Title 21 - Food and Drugs last revised: Apr 28, 2025

View all text of Subpart E [§ 312.80 - § 312.88]

§ 312.87 - Active monitoring of conduct and evaluation of clinical trials.

For drugs covered under this section, the Commissioner and other agency officials will monitor the progress of the conduct and evaluation of clinical trials and be involved in facilitating their appropriate progress.

authority: 21 U.S.C. 321,331,351,352,353,355,360bbb,371; 42 U.S.C. 262.

source: 52 FR 8831, Mar. 19, 1987, unless otherwise noted.

cite as: 21 CFR 312.87